Differentiation and molecular profiling of human embryonic stem cell-derived corneal epithelial cells

Joanna Brzeszczynska, K. Samuel, S. Greenhough, K. Ramaesh, B. Dhillon, D.C. Hay, J.A. Ross

Research output: Contribution to journalArticle

Abstract

It has been suggested that the isolation of scalable populations of limbal stem cells may lead to radical changes in ocular therapy. In particular, the derivation and transplantation of corneal stem cells from these populations may result in therapies providing clinical normality of the diseased or damaged cornea. Although feasible in theory, the lack of donor material in sufficient quantity and quality currently limits such a strategy. A potential scalable source of corneal cells could be derived from pluripotent stem cells (PSCs). We developed an in vitro and serum-free corneal differentiation model which displays significant promise. Our stepwise differentiation model was designed with reference to development and gave rise to cells which displayed similarities to epithelial progenitor cells which can be specified to cells displaying a corneal epithelial phenotype. We believe our approach is novel, provides a robust model of human development and in the future, may facilitate the generation of corneal epithelial cells that are suitable for clinical use. Additionally, we demonstrate that following continued cell culture, stem cell-derived corneal epithelial cells undergo transdifferentiation and exhibit squamous metaplasia and therefore, also offer an in vitro model of disease.
Original languageEnglish
Pages (from-to)1597-1606
Number of pages10
JournalInternational Journal of Molecular Medicine
Volume33
Issue number6
DOIs
Publication statusE-pub ahead of print - 27 Mar 2014

Fingerprint

Stem Cells
Epithelial Cells
Cell Transdifferentiation
Pluripotent Stem Cells
Metaplasia
Human Development
Stem Cell Transplantation
Cornea
Population
Cell Culture Techniques
Phenotype
Therapeutics
Serum
Human Embryonic Stem Cells
In Vitro Techniques

Cite this

Brzeszczynska, Joanna ; Samuel, K. ; Greenhough, S. ; Ramaesh, K. ; Dhillon, B. ; Hay, D.C. ; Ross, J.A. / Differentiation and molecular profiling of human embryonic stem cell-derived corneal epithelial cells. In: International Journal of Molecular Medicine. 2014 ; Vol. 33, No. 6. pp. 1597-1606.
@article{493fa1f89ff94d3095677b55e5e6d913,
title = "Differentiation and molecular profiling of human embryonic stem cell-derived corneal epithelial cells",
abstract = "It has been suggested that the isolation of scalable populations of limbal stem cells may lead to radical changes in ocular therapy. In particular, the derivation and transplantation of corneal stem cells from these populations may result in therapies providing clinical normality of the diseased or damaged cornea. Although feasible in theory, the lack of donor material in sufficient quantity and quality currently limits such a strategy. A potential scalable source of corneal cells could be derived from pluripotent stem cells (PSCs). We developed an in vitro and serum-free corneal differentiation model which displays significant promise. Our stepwise differentiation model was designed with reference to development and gave rise to cells which displayed similarities to epithelial progenitor cells which can be specified to cells displaying a corneal epithelial phenotype. We believe our approach is novel, provides a robust model of human development and in the future, may facilitate the generation of corneal epithelial cells that are suitable for clinical use. Additionally, we demonstrate that following continued cell culture, stem cell-derived corneal epithelial cells undergo transdifferentiation and exhibit squamous metaplasia and therefore, also offer an in vitro model of disease.",
author = "Joanna Brzeszczynska and K. Samuel and S. Greenhough and K. Ramaesh and B. Dhillon and D.C. Hay and J.A. Ross",
year = "2014",
month = "3",
day = "27",
doi = "10.3892/ijmm.2014.1714",
language = "English",
volume = "33",
pages = "1597--1606",
journal = "International Journal of Molecular Medicine",
issn = "1107-3756",
publisher = "Spandidos Publications",
number = "6",

}

Differentiation and molecular profiling of human embryonic stem cell-derived corneal epithelial cells. / Brzeszczynska, Joanna; Samuel, K.; Greenhough, S.; Ramaesh, K.; Dhillon, B.; Hay, D.C.; Ross, J.A.

In: International Journal of Molecular Medicine, Vol. 33, No. 6, 27.03.2014, p. 1597-1606.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Differentiation and molecular profiling of human embryonic stem cell-derived corneal epithelial cells

AU - Brzeszczynska, Joanna

AU - Samuel, K.

AU - Greenhough, S.

AU - Ramaesh, K.

AU - Dhillon, B.

AU - Hay, D.C.

AU - Ross, J.A.

PY - 2014/3/27

Y1 - 2014/3/27

N2 - It has been suggested that the isolation of scalable populations of limbal stem cells may lead to radical changes in ocular therapy. In particular, the derivation and transplantation of corneal stem cells from these populations may result in therapies providing clinical normality of the diseased or damaged cornea. Although feasible in theory, the lack of donor material in sufficient quantity and quality currently limits such a strategy. A potential scalable source of corneal cells could be derived from pluripotent stem cells (PSCs). We developed an in vitro and serum-free corneal differentiation model which displays significant promise. Our stepwise differentiation model was designed with reference to development and gave rise to cells which displayed similarities to epithelial progenitor cells which can be specified to cells displaying a corneal epithelial phenotype. We believe our approach is novel, provides a robust model of human development and in the future, may facilitate the generation of corneal epithelial cells that are suitable for clinical use. Additionally, we demonstrate that following continued cell culture, stem cell-derived corneal epithelial cells undergo transdifferentiation and exhibit squamous metaplasia and therefore, also offer an in vitro model of disease.

AB - It has been suggested that the isolation of scalable populations of limbal stem cells may lead to radical changes in ocular therapy. In particular, the derivation and transplantation of corneal stem cells from these populations may result in therapies providing clinical normality of the diseased or damaged cornea. Although feasible in theory, the lack of donor material in sufficient quantity and quality currently limits such a strategy. A potential scalable source of corneal cells could be derived from pluripotent stem cells (PSCs). We developed an in vitro and serum-free corneal differentiation model which displays significant promise. Our stepwise differentiation model was designed with reference to development and gave rise to cells which displayed similarities to epithelial progenitor cells which can be specified to cells displaying a corneal epithelial phenotype. We believe our approach is novel, provides a robust model of human development and in the future, may facilitate the generation of corneal epithelial cells that are suitable for clinical use. Additionally, we demonstrate that following continued cell culture, stem cell-derived corneal epithelial cells undergo transdifferentiation and exhibit squamous metaplasia and therefore, also offer an in vitro model of disease.

U2 - 10.3892/ijmm.2014.1714

DO - 10.3892/ijmm.2014.1714

M3 - Article

VL - 33

SP - 1597

EP - 1606

JO - International Journal of Molecular Medicine

JF - International Journal of Molecular Medicine

SN - 1107-3756

IS - 6

ER -